Aetion, a software platform company that delivers real-world analytics and evidence needed for biopharma and payers to engage in value-based care, has raised $36.4 million in Series B funding. The round was led by New Enterprise Associates (NEA) and included a new investor, Amgen Ventures, alongside existing investors Flare Capital Partners, Lakestar and Oxeon Ventures. Mohamad Makhzoumi of NEA will join the Aetion board of directors.With the addition of the $36 million, Aetion has raised a
Read More
Aetion
Aetion Raises $11.2M for Real-World Evidence Data Analytics Platform
Aetion, a NYC-based healthcare technology company that delivers the real-world analytics and evidence needed for value-based healthcare has raised $11.2 million in Series A funding led by Flare Capital Partners and joined by Lakestar. The company plans to utilize the funding to extend the capabilities of its real-world evidence platform, as well as expand and commercialize its solutions for the benefit of the healthcare ecosystem. The platform enables payers and providers to collaborate in
Read More
